DiagnosticON Joins the NVIDIA Inception Program: A Milestone Achievement
Company Announcement Today, we are thrilled to announce that DiagnosticON has reached yet another remarkable landmark in its journey...
Read MoreWelcome to DiagnosticON
We are proud to introduce DiagnosticON, an artificial intelligence-based risk evaluation system designed to automate and enhance the detection of early signs of serious short-term complications after acute myocardial infarction and heart failure. By leveraging patient characteristics and ECG findings, DiagnosticON aims to provide a comprehensive solution to improve patient outcomes, promote timely medical intervention and prevent hospital readmissions.
The largest hospital systems globally, including those in the US, UK, and Germany, are implementing programs to link payment to the quality of hospital care. This includes penalizing hospitals when patients with acute myocardial infarction and heart failure experience unplanned readmission due to complications within 30 days after hospital discharge. Despite these efforts, many of patients are still being readmitted to the hospital within 30 days after discharge.
We aim to assist hospitals in the US and Europe in achieving an optimal operational point - delivering maximum patient health outcomes with minimal investments and avoiding penalties.
Compared to physician judgment during discharge, DiagnosticON provides:
Discover More
We are delighted to offer three AI modules and two AI platforms, each available in two variants: either as a web-calculator or as a combination of a web-calculator and an EHR-compatible fully automated system.
DiagnosticON AMI is an AI module designed to assess the risk of hospital readmission within 30 days after acute myocardial infarction (AMI), utilizing patient characteristics as its key predictors.
DiagnosticON HF is an AI module aimed at evaluating the risk of hospital readmission within 30 days after hospitalization for heart failure (HF), leveraging patient characteristics as its primary factors.
DiagnosticON ECG is an AI module designed to assess the risk of hospital readmission within 30 days ECG findings.
DiagnosticON ECG Plus is an AI module designed to assess the risk of hospital readmission within 30 days after AMI and HF, utilizing patient characteristics and ECG findings..
The DiagnosticON Premium System combines AI modules for AMI and HF, integrating predictions based on patient characteristics and ECG findings.
DiagnosticON RM is a technology employing a remote monitoring skin patch to gather vital signs from patients suffering from Acute Myocardial Infarction (AMI) and Heart Failure (HF). The collected data is then processed by an AI system, capable of predicting serious complications. If the risk is high, the system promptly alerts healthcare professionals, facilitating early medical intervention and potentially averting severe disabilities or even death.
More information about the technology will be revealed in due course.
Currently, nearly 6.5 million Americans over the age of 20 are living with heart failure. This figure is expected to increase to 8.5 million by 2030. An estimated 960,000 new heart failure cases are reported annually. Heart failure is responsible for about 8.5% of all heart disease-related deaths in the United States. In 2018, heart failure was mentioned in 379,800 death certificates, accounting for 13.4% of all deaths. Heart failure remains the leading cause of hospitalizations among the Medicare population. Consequently, Medicare has started implementing programs that tie payment to the quality of hospital care. This includes penalties for hospitals if patients with heart failure experience unplanned readmissions due to complications within 30 days after hospital discharge (Medicare Hospital Readmissions Reduction Program).
Watch MoreAs a dynamic AI startup, we are committed to keeping you connected with the cutting-edge advancements we're making in the field. Here, we'll share our latest news, industry insights, product launches, and significant milestones. Dive in to discover how we're shaping the future of technology and driving change in the industry.
Company Announcement Today, we are thrilled to announce that DiagnosticON has reached yet another remarkable landmark in its journey...
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod...
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod...
Read MoreThe best way to predict the future is to invent it.
Alan Kay
Computer ScientistMedicine is a science of uncertainty and an art of probability.
It is far better to foresee even without certainty than not to foresee at all.
As a forward-thinking startup focused on leveraging Artificial Intelligence for healthcare, we are always seeking strategic alliances that can enhance our mission to revolutionize patient care. Whether you're a tech firm, healthcare provider, or research institution, there's room to collaborate and make a significant impact in the health landscape.
We are deeply committed to forging strong alliances with academic institutions as part of our innovation journey.
At DiagnosticON, we firmly believe in the power of collaboration and are keen on fostering strong partnerships with healthcare institutions worldwide.
DiagnosticON Seeks Collaborative Opportunities with MedTech and Pharma Industries
Pre-register now for early access to DiagnosticON